Latest News

New compound to treat depression identified

A compound, hydroxynorketamine (HNK), has been identified by researchers that may treat symptoms of depression just as effectively and rapidly as ketamine, without the unwanted side effects associated with the psychoactive drug, according to a study. Interestingly, use of HNK may also serve as a future therapeutic approach for treating neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, the authors note.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Enriched blood cells preserve cognition in mice with features of Alzheimer's disease

  • Brain abnormalities in people with schizophrenia identified

  • Brain imaging shows how children inherit their parents' anxiety

  • Pupil response predicts depression risk in kids

  • Study reveals brain network responsible for cognitive changes in multiple sclerosis

  • Schwann cells 'dine in' to clear myelin from injured nerves

  • Reducing stroke damage may be next for optical coherence tomography technology widely used in vision healthcare

  • Uncovering the mechanism of our oldest anesthetic

  • Health information causing new moms anxiety

  • Statins linked to lower aggression in men, but higher in women

  •